TwinBeech Capital’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$567K Buy
+30,456
New +$763K 0.13% 212

Other funds holding BCAX

TwinBeech Capital's BCAX Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 30,456 shares worth $567K. The stake represents 0.13% of the portfolio and ranks #212 among its holdings.

169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • TwinBeech Capital held 30,456 shares of Bicara Therapeutics worth $567K as of Q3 2026.
  • Bicara Therapeutics was a new TwinBeech Capital position in Q3 2026.
  • Bicara Therapeutics made up 0.13% of TwinBeech Capital's portfolio in Q3 2026, its #212 holding.
  • 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.